Trials / Unknown
UnknownNCT05364710
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
Clinical Poof-of-concept Study on Rapid Immune Modulating Effects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Natural Immune Systems Inc · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Clinical-proof-of concept study, comparing the acute immune impacts of of 2 doses of a novel blend of supplements to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 2 different doses of the blend at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the blend on immune function as compared to the placebo.
Detailed description
Clinical-proof-of-concept study comparing the acute immune effects of 2 doses of a nutraceutical blend, and a placebo. The nutraceutical blend is based on a transfer factor isolated from cow colostrum ultrafiltrate. 24 subjects will participate in a placebo-controlled, randomized, double-blinded, cross-over study design, wherein they will be taking placebo, dose 1, and dose 2, each separated by a 1-week washout period. Blood samples are taken 1 hour after participants arrive; the dose is then administered. Samples are taken 1 hour, 2 hours, and 24 hours following administration. At each blood sample collection, a spit sample will also be taken for salivary IgA testing. A series of immune panels will be used to determine the acute impacts on immune surveillance, immune cell activation status, immune cell priming, and cytokine profiles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Transfer factor from colostrum ultrafiltrate | Proteins that confer immune protection, isolated from cow colostrum ultrafiltrate and used to promote immune health and surveillance. |
Timeline
- Start date
- 2022-05-07
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2022-05-06
- Last updated
- 2022-05-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05364710. Inclusion in this directory is not an endorsement.